论文部分内容阅读
目的 :评价连续性血透治疗急性肾功能衰竭 (ARF)的疗效。方法 :对比分析连续性血液透析 (CHD)组 6 3例与间歇性血液透析(IHD)组 38例的临床资料及疗效。结果 :CHD组 6 3例 ,存活 5 4例 ( 85 .7% ) ,死亡 9例 ( 14 .3% ) ;IHD组 38例 ,存活 2 6例 ( 6 8.4% ) ,死亡 12例 ( 31.6 % ) ,两组有差别 (P <0 .0 5 ) ,CHD组血流动力学稳定 ,氮质血症控制更佳 ,APF持续时间较充盈。结论 :CHD治疗ARF的疗效优于IHD ,提高血透质量和存活率。
Objective: To evaluate the efficacy of continuous hemodialysis in the treatment of acute renal failure (ARF). Methods: The clinical data and curative effect of 38 consecutive patients with hemodialysis (CHD) and 38 patients with intermittent hemodialysis (IHD) were analyzed. Results: 63 cases (85.7%) survived in CHD group and 9 (14.3%) died in the CHD group, 38 cases in IHD group, 26 cases survived (6 8.4%) and 12 died (31.6% ), There was a significant difference between the two groups (P <0.05). The CHD group had stable hemodynamics, better control of azotemia and longer duration of APF. Conclusion: The therapeutic effect of CHD on ARF is better than that of IHD, and hemodialysis quality and survival rate are improved.